Maravai Lifesciences Holdings
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $47,397 | $46,850 | $56,406 | $65,200 |
Gross Profit | 7,768 | 7,725 | 18,962 | 28,374 |
EBITDA | -66,278 | -49,162 | -20,713 | -147,971 |
EBIT | -64,072 | -35,239 | -162,010 | |
Net Income | -39,591 | -29,945 | -26,145 | -99,038 |
Net Change In Cash | 47,397 | 46,850 | 56,406 | 65,200 |
Free Cash Flow | -13,139 | -14,625 | -20,987 | 4,545 |
Cash | 269,907 | 285,053 | 322,399 | 578,157 |
Basic Shares | 144,236 | 143,425 | 139,730 | 141,555 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $259,185 | $288,945 | $883,001 | $799,240 |
Gross Profit | 108,309 | 140,202 | 714,044 | 658,679 |
EBITDA | -156,917 | 712,409 | 609,989 | 585,777 |
EBIT | -213,782 | 663,628 | 571,886 | 561,025 |
Net Income | -144,846 | -119,029 | 220,205 | 182,037 |
Net Change In Cash | 259,185 | 288,945 | 883,001 | 799,240 |
Cost of Revenue | 315,176 | |||
Free Cash Flow | -22,193 | 60,671 | 518,887 | 353,720 |
Cash | 322,399 | 574,962 | 632,138 | 551,272 |
Basic Shares | 137,906 | 131,919 | 131,695 | 121,965 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.08 |
2025-03-31 | -$0.02 |
2024-12-31 | -$0.06 |
